Insiders · SEPN

Shalini Sharp

Director at Septerna, Inc. (SEPN)

Shalini Sharp has filed 30 insider reports with the SEC since February 2021, as director at Septerna, Inc. (SEPN), director at BeOne Medicines Ltd. (ONC) and director at Organon & Co. (OGN) and at 5 more companies. Shalini Sharp made no open-market purchases or sales in the last 12 months. The latest filing, on June 30, 2026, reports grant or award at Septerna, Inc. (SEPN).

Filings
30
Companies
8
Bought on market
None
Sold on market
$157K

Companies where Shalini Sharp is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Septerna, Inc. logo
SEPN
Septerna, Inc.
Director$39.45Jun 30, 2026
BeOne Medicines Ltd. logo
ONC
BeOne Medicines Ltd.
Directorsince September 202438,116$403.60Jun 15, 2026
Organon & Co. logo
OGN
Organon & Co.
Director2$13.92Jun 15, 2026
Neurocrine Biosciences Inc logo
NBIX
Neurocrine Biosciences Inc
Director4,088$157K$162.86May 29, 2026
Mirati Therapeutics, Inc. logo
MRTX
Mirati Therapeutics, Inc.
Directorsince March 20210Jan 24, 2024
Sutro Biopharma, Inc. logo
STRO
Sutro Biopharma, Inc.
Director$8.50Jun 8, 2022
Precision Biosciences Inc logo
DTIL
Precision Biosciences Inc
Director$7.10May 12, 2021
Nuvation Bio Inc. logo
NUVB
Nuvation Bio Inc.
Director35,000$3.78Feb 27, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Shalini Sharp.

Compare Shalini Sharp with

Other insiders at the same companies

Questions about Shalini Sharp

What is Shalini Sharp's role at Septerna, Inc.?
Shalini Sharp reports to the SEC as director at Septerna, Inc. (SEPN), according to the latest filing on June 30, 2026. Shalini Sharp has also filed as director at BeOne Medicines Ltd. (ONC), director at Organon & Co. (OGN), director at Neurocrine Biosciences Inc (NBIX) and director at Mirati Therapeutics, Inc. (MRTX).
How many shares does Shalini Sharp own?
After the latest filing that states it, Shalini Sharp directly owned 38,116 shares of BeOne Medicines Ltd. (ONC), 2 shares of Organon & Co. (OGN), 4,088 shares of Neurocrine Biosciences Inc (NBIX) and 35,000 shares of Nuvation Bio Inc. (NUVB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Shalini Sharp bought or sold stock recently?
The most recent open-market sale was on May 17, 2024: sold 1,106 shares of Neurocrine Biosciences Inc (NBIX) for $157K at an average of $141.90.
How do I get alerts when Shalini Sharp files?
Follow Shalini Sharp on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Shalini Sharp (SEC CIK 0001377202). Totals count each trade once, skipping amendments whose original is on file, from Feb 27, 2021 on. View on SEC EDGAR